B-cell small lymphocytic lymphoma – Basic Information

Go back

B-cell small lymphocytic lymphoma is a slow-growing blood cancer that develops in the lymphatic system, often progressing silently for months or years before causing any noticeable symptoms.

Understanding B-cell Small Lymphocytic Lymphoma

B-cell small lymphocytic lymphoma, commonly called SLL, is a type of cancer that affects white blood cells known as B lymphocytes, which are cells that help your body fight infections. In this condition, these B cells become abnormal and multiply too much, eventually forming tumors in various parts of the body. The cancer primarily affects the lymphatic system, which is a large network of organs, vessels, and tissues that work as part of your immune system to protect you from disease.[1]

SLL belongs to a larger group of cancers called non-Hodgkin lymphoma. What makes SLL unique is that it grows slowly compared to many other types of lymphoma. This slow growth is why doctors sometimes describe it as an “indolent” lymphoma. The word indolent simply means slow-growing or not aggressive. While this might sound reassuring, it doesn’t mean the disease is harmless—it just means it often takes more time to develop and may not require immediate treatment in all cases.[2]

SLL and another condition called chronic lymphocytic leukemia (CLL) are actually considered different versions of the same disease. Both start in B cells and behave similarly, so doctors treat them in the same way. The main difference lies in where the cancer cells are found. In SLL, the abnormal cells are primarily located in the lymph nodes and spleen, while in CLL, they’re mainly found in the blood and bone marrow.[5]

Sometimes, SLL can transform into a more aggressive type of lymphoma called diffuse large B-cell lymphoma. This change is known as Richter transformation. When this happens, the treatment approach changes to match the more aggressive nature of the disease.[13]

How Common Is This Disease

B-cell lymphomas are quite common among lymphomas, accounting for 85% of all non-Hodgkin lymphomas. In 2024, the American Cancer Society estimated that about 80,600 people would receive a diagnosis of non-Hodgkin lymphoma in the United States. When compared to the more than 2 million people who learn they have some type of cancer each year, lymphoma represents a smaller portion of all cancers.[3]

Small lymphocytic lymphoma typically affects older adults. Most people diagnosed with SLL are over the age of 60, with the average age at diagnosis being around 65 years old. SLL accounts for approximately 2 to 3 percent of all adult lymphomas, making it a relatively uncommon type within the broader category of lymphomas.[21]

The slow-growing nature of SLL means that many people may have the condition for years without knowing it. Some individuals only discover they have SLL during routine medical tests or examinations for unrelated health issues. This delayed detection is common because the disease can exist quietly in the body without causing obvious problems for a long time.[3]

What Causes Small Lymphocytic Lymphoma

The exact cause of small lymphocytic lymphoma remains unknown. What doctors do know is that the disease begins when something goes wrong with B lymphocytes, causing them to become abnormal. These abnormal cells then multiply uncontrollably, building up in the lymph nodes, spleen, and other parts of the lymphatic system. Unlike healthy B cells that help protect the body, these cancer cells don’t function properly and crowd out normal blood cells.[11]

B-cell small lymphocytic lymphoma is not contagious, meaning it cannot spread from person to person through contact, sharing items, or any other form of transmission. The disease develops internally due to changes in the body’s own cells. Scientists continue to research what triggers these cellular changes, but the process involves complex genetic and molecular alterations within the B lymphocytes that cause them to lose their normal growth controls.[2]

The cancer cells in SLL develop in the lymphatic system, which includes lymph nodes scattered throughout the body, the spleen, bone marrow, and other lymphoid organs. Because the lymphatic system extends to so many areas of the body, SLL can affect multiple locations. The abnormal cells can be found in lymph nodes in the neck, underarms, or groin, as well as in the spleen, blood, and bone marrow.[5]

Who Is at Higher Risk

While anyone can develop small lymphocytic lymphoma, certain factors appear to increase the likelihood of developing this condition. Age is one of the most significant risk factors. SLL usually occurs in older adults, with most people diagnosed being over 60 years old. The disease is quite rare in younger people and children.[21]

Understanding risk factors can be helpful, but it’s important to remember that having one or more risk factors doesn’t mean someone will definitely develop SLL. Many people with risk factors never develop the disease, while some people with no known risk factors do develop it. Risk factors simply mean the chance is higher than average, not that the disease is certain or inevitable.[3]

⚠️ Important
Small lymphocytic lymphoma typically affects older adults and often grows slowly without causing symptoms for years. Because of this, many people are diagnosed during routine check-ups or tests for other conditions. If you notice any unusual symptoms such as swollen lymph nodes, unexplained fatigue, or night sweats, it’s important to discuss them with your healthcare provider even if they seem minor.

Recognizing the Symptoms

One of the most challenging aspects of small lymphocytic lymphoma is that it often causes no symptoms in its early stages. Many people with SLL feel completely healthy and have no idea they have the disease. Some people live with SLL for months or even years before any signs appear. In fact, people with SLL are sometimes diagnosed during routine blood tests or medical examinations for completely unrelated health concerns.[5]

When symptoms do develop, they tend to appear gradually as the disease progresses. The most common symptom is painless swelling of the lymph nodes. You might notice lumps under the skin in your neck, underarms, or groin area. These swollen lymph nodes usually don’t hurt, which is why they might go unnoticed or be dismissed as unimportant. The lymph nodes may feel firm and can range from the size of a pea to much larger.[3]

Drenching night sweats are another symptom that can occur with SLL. These are not just ordinary sweating from being too warm—they’re intense enough to soak through your nightclothes and bed sheets. Night sweats from lymphoma typically happen repeatedly over time, not just once or twice. They can disrupt sleep and leave you feeling exhausted.[3]

Fatigue is a common complaint among people with SLL. This isn’t just feeling tired after a busy day—it’s a deep, persistent exhaustion that doesn’t improve with rest. This overwhelming tiredness can make it difficult to carry out daily activities and can significantly affect quality of life. The fatigue occurs because the abnormal lymphocytes crowd out healthy blood cells, reducing the body’s ability to carry oxygen and fight infections effectively.[11]

Some people with SLL experience abdominal pain or a feeling of fullness in the belly. This happens when the spleen or liver becomes enlarged due to the buildup of lymphoma cells. An enlarged spleen can press on the stomach, making you feel full even after eating only a small amount of food. This can lead to unintended weight loss because you don’t feel like eating as much as usual.[3]

Other symptoms may include unexplained fever, which comes and goes without any obvious infection, and unintentional weight loss. Losing weight without trying—typically defined as losing 10% or more of your body weight over six months—can be a sign that something is wrong. Some people also experience frequent infections because the abnormal B cells cannot fight off bacteria and viruses effectively.[5]

Preventing Small Lymphocytic Lymphoma

Unfortunately, there are no known ways to prevent small lymphocytic lymphoma. Because scientists don’t fully understand what causes the disease or what triggers the changes in B lymphocytes that lead to cancer, there are no specific lifestyle changes, vaccinations, or supplements that can prevent SLL from developing. Unlike some other diseases where clear risk factors like smoking or diet play a role, SLL doesn’t have modifiable risk factors that you can change to reduce your risk.[2]

However, maintaining overall good health through a balanced diet, regular exercise, and routine medical check-ups is always beneficial for your wellbeing. While these healthy habits won’t prevent SLL specifically, they support your immune system and overall health, which is important for managing any health condition that may arise. Regular visits to your doctor can help catch SLL and other health problems early, when they may be easier to manage.[22]

How the Disease Affects the Body

To understand how small lymphocytic lymphoma affects the body, it helps to know what happens when the disease develops. Normally, B lymphocytes are produced in the bone marrow and mature into cells that help fight infections. In SLL, something goes wrong in this process. The B cells become abnormal and instead of dying off naturally as old cells should, they continue to live and multiply.[12]

As these abnormal B cells accumulate, they crowd into the lymph nodes, causing them to swell. The lymph nodes are small, bean-shaped structures scattered throughout the body that act as filters for the lymphatic system. When they fill with cancer cells, they can become noticeably enlarged. The spleen, another part of the lymphatic system located in the upper left side of your abdomen, can also become enlarged as abnormal cells accumulate there.[5]

The buildup of abnormal lymphocytes doesn’t just cause swelling—it also interferes with normal blood cell production. These cancer cells can crowd out the bone marrow, the soft tissue inside bones where blood cells are made. This crowding effect reduces the production of healthy red blood cells, white blood cells, and platelets. Red blood cells carry oxygen throughout your body, so when their numbers drop, you may feel tired and short of breath. White blood cells fight infection, so having too few makes you more vulnerable to getting sick. Platelets help blood clot, so low platelet counts can cause easy bruising or bleeding.[11]

The abnormal B lymphocytes in SLL also don’t function properly as infection fighters. Even though there may be many B cells in your body, they’re not working correctly to produce the antibodies you need to fight off bacteria and viruses. This immune system weakness means people with SLL are more prone to infections, which can range from mild to serious.[12]

In some cases, SLL cells produce abnormal proteins that can build up in the blood. These proteins can make the blood thicker than normal or affect other organs. The cancer cells can also release substances that cause inflammation throughout the body, contributing to symptoms like fever and weight loss. When lymphoma cells accumulate in organs like the liver or lungs, they can interfere with how those organs function, though this is less common in slow-growing SLL than in more aggressive lymphomas.[5]

Despite affecting multiple body systems, SLL’s slow growth means these changes usually develop gradually. This gives the body time to adapt somewhat, which is why many people don’t notice symptoms immediately. However, over time, as more cancer cells accumulate and crowd out healthy cells, the effects become more noticeable and treatment becomes necessary.[2]

⚠️ Important
Small lymphocytic lymphoma is closely related to chronic lymphocytic leukemia and they are considered versions of the same disease. If you have been diagnosed with either SLL or CLL, your doctor will use similar treatment approaches because the diseases behave in the same way. The main difference is simply where the cancer cells are most concentrated in your body—lymph nodes and spleen for SLL, or blood and bone marrow for CLL.

Ongoing Clinical Trials on B-cell small lymphocytic lymphoma

  • Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Belgium Czechia Denmark Germany Greece Norway +4
  • A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium France Germany Italy The Netherlands +4
  • Study of NX-5948 in adults with relapsed or resistant chronic lymphocytic leukemia and small lymphocytic lymphoma who previously received BTK inhibitor and BCL-2 inhibitor treatment

    Recruiting

    2 1 1
    Investigated diseases:
    France Hungary Italy Poland
  • A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Czechia France Germany Italy The Netherlands Poland +3
  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark Finland France +8
  • Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

    Recruiting

    2 1 1 1
    Investigated drugs:
    Spain
  • Study of Ibrutinib and Obinutuzumab for Patients with Chronic Lymphocytic Leukemia Who Have Not Received Treatment Before

    Recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated drugs:
    Czechia France Hungary Italy Poland Spain
  • Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Denmark Germany The Netherlands
  • Phase 3 Randomized Study of Rituximab plus Venetoclax for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Patients

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands

References

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/small-lymphocytic-lymphoma/

https://www.mayoclinic.org/diseases-conditions/b-cell-lymphoma/symptoms-causes/syc-20586599

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://www.cancer.org/cancer/types/non-hodgkin-lymphoma/about/b-cell-lymphoma.html

https://www.mayoclinic.org/diseases-conditions/small-lymphocytic-lymphoma/symptoms-causes/syc-20590910

https://cllsociety.org/information-on-small-lymphocytic-lymphoma/

https://www.mdanderson.org/cancer-types/non-hodgkin-lymphoma/b-cell-lymphoma.html

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/small-lymphocytic-lymphoma/

https://www.mayoclinic.org/diseases-conditions/small-lymphocytic-lymphoma/diagnosis-treatment/drc-20590926

https://www.cancer.org/cancer/types/non-hodgkin-lymphoma/treating/b-cell-lymphoma.html

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC4841457/

https://cancer.ca/en/cancer-information/cancer-types/non-hodgkin-lymphoma/treatment/treatment-by-type/small-lymphocytic-lymphoma

https://clinicaltrials.ucsf.edu/small-lymphocytic-lymphoma

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://cllsociety.org/information-on-small-lymphocytic-lymphoma/

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/small-lymphocytic-lymphoma/

https://lymphoma-action.org.uk/about-lymphoma/living-and-beyond-lymphoma

https://cllsociety.org/cll-sll-patient-education-toolkit/recognizing-when-it-is-time-to-treat/

https://www.mayoclinic.org/diseases-conditions/small-lymphocytic-lymphoma/diagnosis-treatment/drc-20590926

https://nhoreviveresearch.com/blogs/know-about-small-lymphocytic-lymphoma-sll/

https://www.myleukemiateam.com/resources/8-ways-to-live-better-with-cll

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Is small lymphocytic lymphoma the same as chronic lymphocytic leukemia?

Small lymphocytic lymphoma and chronic lymphocytic leukemia are considered different manifestations of the same disease. They both start in B cells and are treated in the same way. The main difference is location: in SLL, cancer cells are mostly found in the lymph nodes and spleen, while in CLL they’re mainly in the blood and bone marrow.

Why don’t I have symptoms if I have small lymphocytic lymphoma?

Small lymphocytic lymphoma grows very slowly, which is why many people don’t have symptoms for months or years. The cancer develops gradually, giving your body time to adapt to the changes. Some people are diagnosed during routine tests before any symptoms appear. Symptoms typically develop as the disease progresses and more cancer cells accumulate.

Can small lymphocytic lymphoma be cured?

Treatments usually cannot cure small lymphocytic lymphoma, but they can control it for a long time. Many people with SLL maintain a good quality of life for many years with proper management. Some treatments can put the disease into remission, meaning symptoms disappear and tests don’t find signs of cancer, though the condition can come back.

Do I need treatment right away if I’m diagnosed with SLL?

Not everyone with small lymphocytic lymphoma needs treatment immediately. Because it grows slowly, your doctor may recommend a “watch and wait” approach if you don’t have symptoms or if the disease isn’t causing problems. Treatment typically begins when symptoms develop or the disease starts to progress.

What is Richter transformation?

Richter transformation occurs when small lymphocytic lymphoma changes into a more aggressive type of lymphoma called diffuse large B-cell lymphoma. When this happens, the treatment approach changes because the disease starts growing and spreading more quickly. Your doctor will monitor for signs of transformation during your care.

🎯 Key takeaways

  • Small lymphocytic lymphoma is a slow-growing blood cancer that affects B lymphocytes and primarily involves the lymph nodes and spleen.
  • SLL and chronic lymphocytic leukemia are essentially the same disease, just with cancer cells located in different parts of the body.
  • Many people live with SLL for years without symptoms, and some are diagnosed completely by accident during routine medical tests.
  • The disease typically affects older adults, with most people diagnosed being over 60 years old.
  • Common symptoms include painless swollen lymph nodes, drenching night sweats, persistent fatigue, and unintended weight loss.
  • There are no known ways to prevent SLL because the exact cause remains unknown.
  • While treatments usually can’t cure SLL, they can control the disease for long periods and help people maintain good quality of life.
  • Not everyone needs treatment immediately—some people can follow a “watch and wait” approach if the disease isn’t causing problems.